NASDAQ:AIPT - Precision Therapeutics News Headlines

Sign in or create an account to add this stock to your watchlist.
$0.85 +0.02 (+2.41 %)
(As of 03/21/2019 08:56 AM ET)
Previous Close$0.8315
Today's Range$0.83 - $0.87
52-Week Range$0.60 - $1.58
Volume49,095 shs
Average Volume70,876 shs
Market Capitalization$12.19 million
P/E RatioN/A
Dividend YieldN/A
Beta2.07

Headlines

Precision Therapeutics (NASDAQ AIPT) News Headlines

Source:
DateHeadline
Precision Therapeutics IncPrecision Therapeutics Inc
www.bloomberg.com - March 19 at 12:04 PM
Precision Therapeutics Extends Exchange Offer for Helomics Notes and WarrantsPrecision Therapeutics Extends Exchange Offer for Helomics Notes and Warrants
finance.yahoo.com - March 14 at 12:06 PM
Head to Head Comparison: Precision Therapeutics (AIPT) and Wound Management Technologies (WNDM)Head to Head Comparison: Precision Therapeutics (AIPT) and Wound Management Technologies (WNDM)
www.americanbankingnews.com - March 7 at 9:21 PM
Company Concluded 2018 With 38 Percent Increase in STREAMWAY System DisposablesCompany Concluded 2018 With 38 Percent Increase in STREAMWAY System Disposables
globenewswire.com - March 6 at 4:10 PM
Histogenics (HSGX) and Precision Therapeutics (AIPT) Financial ContrastHistogenics (HSGX) and Precision Therapeutics (AIPT) Financial Contrast
www.americanbankingnews.com - March 6 at 3:32 PM
Sarepta Therapeutics Announces Pricing of $375.0 Million Public Offering of Common Stock - GlobeNewswireSarepta Therapeutics Announces Pricing of $375.0 Million Public Offering of Common Stock - GlobeNewswire
globenewswire.com - March 6 at 11:35 AM
Precision Therapeutics’ Skyline Medical Division Captures Market Share in Saudi Arabia Via New Orders While Disposable Sales Show Significant Year-Over-Year IncreasePrecision Therapeutics’ Skyline Medical Division Captures Market Share in Saudi Arabia Via New Orders While Disposable Sales Show Significant Year-Over-Year Increase
finance.yahoo.com - March 5 at 9:59 AM
Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc.Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc.
finance.yahoo.com - March 1 at 4:01 PM
Histogenics (HSGX) and Precision Therapeutics (AIPT) Critical ReviewHistogenics (HSGX) and Precision Therapeutics (AIPT) Critical Review
www.americanbankingnews.com - February 27 at 7:20 PM
Precision Therapeutics Inc. Announces Proposed Public Offering of SecuritiesPrecision Therapeutics Inc. Announces Proposed Public Offering of Securities
finance.yahoo.com - February 27 at 11:55 AM
Precision Therapeutics Inc. Announces Pricing of Public Offering of Up to $1.26 Million of UnitsPrecision Therapeutics Inc. Announces Pricing of Public Offering of Up to $1.26 Million of Units
finance.yahoo.com - February 27 at 11:55 AM
Precision Therapeutics Inc. is Excited to Announce a Special Meeting of Stockholders and Commencement of Registered Exchange OfferPrecision Therapeutics Inc. is Excited to Announce a Special Meeting of Stockholders and Commencement of Registered Exchange Offer
finance.yahoo.com - February 19 at 12:03 PM
RL, BOX among premarket gainersRL, BOX among premarket gainers
seekingalpha.com - February 5 at 10:10 AM
Precision Therapeutics’ TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer CellPrecision Therapeutics’ TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer Cell
www.nasdaq.com - February 5 at 10:10 AM
Precision Therapeutics’ TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer Cell Types, Initiating Its Proprietary Process for New Drug Development Via Patient-Derived Tumor ModelsPrecision Therapeutics’ TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer Cell Types, Initiating Its Proprietary Process for New Drug Development Via Patient-Derived Tumor Models
finance.yahoo.com - February 5 at 10:10 AM
Precision establishes Streamway distribution in TaiwanPrecision establishes Streamway distribution in Taiwan
seekingalpha.com - January 25 at 11:06 AM
Precision Therapeutics Has Groundbreaking Approach to Personalized Cancer Treatment, Reports CEOCFO MagazinePrecision Therapeutics Has Groundbreaking Approach to Personalized Cancer Treatment, Reports CEOCFO Magazine
finance.yahoo.com - January 22 at 10:58 AM
Precision Therapeutics CEO invests $1.4M; shares up 3% premarketPrecision Therapeutics' CEO invests $1.4M; shares up 3% premarket
seekingalpha.com - January 20 at 8:56 PM
Precision Therapeutics CEO invests another $1M; shares up 3% premarketPrecision Therapeutics CEO invests another $1M; shares up 3% premarket
seekingalpha.com - January 18 at 9:47 AM
Precision Therapeutics Receives $1,370,000 Investment from CEO and Director, Carl SchwartzPrecision Therapeutics Receives $1,370,000 Investment from CEO and Director, Carl Schwartz
finance.yahoo.com - January 18 at 9:47 AM
Large Sale to Prestigious Health System Further Validates STREAMLINE UtilityLarge Sale to Prestigious Health System Further Validates STREAMLINE Utility
globenewswire.com - January 17 at 1:05 PM
Precision Therapeutics’ Skyline Medical Division Significantly Expands Footprint in New England With Sale of Six STREAMWAY Systems to Yale University Ambulatory Outpatient Surgical CenterPrecision Therapeutics’ Skyline Medical Division Significantly Expands Footprint in New England With Sale of Six STREAMWAY Systems to Yale University Ambulatory Outpatient Surgical Center
finance.yahoo.com - January 17 at 1:05 PM
Precision Therapeutics Inc. (AIPT) CEO Dr. Carl Schwartz on Q3 2018 Results - Earnings Call TranscriptPrecision Therapeutics Inc. (AIPT) CEO Dr. Carl Schwartz on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 17 at 10:16 AM
Precision Therapeutics Reports Third Quarter 2018 Financial ResultsPrecision Therapeutics Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 15 at 10:39 AM
Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian CancerHelomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer
finance.yahoo.com - November 14 at 10:16 AM
Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018
finance.yahoo.com - November 8 at 10:44 AM
BRIEF-Precision Therapeutics Secures Rights To Novel Technology Designed To Develop Cancer DrugsBRIEF-Precision Therapeutics Secures Rights To Novel Technology Designed To Develop Cancer Drugs
www.msn.com - November 7 at 10:59 AM
Precision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its MutationPrecision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutation
finance.yahoo.com - November 7 at 10:59 AM
Precision Therapeutics’ CEO Talks with Uptick Newswire’s Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and What’s on the HorizonPrecision Therapeutics’ CEO Talks with Uptick Newswire’s Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and What’s on the Horizon
finance.yahoo.com - November 5 at 3:31 PM
Filing under Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Precision Therapeutics Inc.: SEC File Nos. 001-36790; and 333-221966Filing under Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Precision Therapeutics Inc.: SEC File Nos. 001-36790; and 333-221966
feeds.benzinga.com - October 29 at 10:10 PM
Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhDPrecision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD
finance.yahoo.com - October 11 at 10:00 AM
Precision Therapeutics sells first Streamway in Europe; shares up 9%Precision Therapeutics sells first Streamway in Europe; shares up 9%
seekingalpha.com - September 27 at 11:58 AM
Precision Therapeutics Secures First STREAMWAY System Sale in EuropePrecision Therapeutics Secures First STREAMWAY System Sale in Europe
finance.yahoo.com - September 27 at 11:58 AM
Dr. Bob Murphy, Head of Computational Biology at Carnegie Mellon University, Joins Precision Therapeutics’ Scientific Advisory BoardDr. Bob Murphy, Head of Computational Biology at Carnegie Mellon University, Joins Precision Therapeutics’ Scientific Advisory Board
finance.yahoo.com - September 26 at 10:54 AM
Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory BoardPrecision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board
finance.yahoo.com - September 11 at 10:56 AM
Precision Therapeutics Forms Scientific Advisory Board to Advance its Strategy in the Precision Medicine SectorPrecision Therapeutics Forms Scientific Advisory Board to Advance its Strategy in the Precision Medicine Sector
finance.yahoo.com - September 6 at 11:00 AM
Precision Therapeutics Inc. (AIPT) CEO Carl Schwartz on Q2 2018 Results - Earnings Call TranscriptPrecision Therapeutics Inc. (AIPT) CEO Carl Schwartz on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 15 at 10:43 AM
Precision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New ‘HelomicsDiscover’ Program to Drive Forward the Next Generation of Precision Cancer TherapiesPrecision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New ‘HelomicsDiscover’ Program to Drive Forward the Next Generation of Precision Cancer Therapies
finance.yahoo.com - August 14 at 11:01 AM
Precision Therapeutics to Hold Business Update Conference Call on August 14, 2018Precision Therapeutics to Hold Business Update Conference Call on August 14, 2018
finance.yahoo.com - August 9 at 11:00 AM
Precision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights PlatformPrecision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platform
finance.yahoo.com - August 9 at 11:00 AM
Precision Therapeutics Making Rapid Progress with Both Personalized Medicine and Unique Medical Waste Disposal SystemPrecision Therapeutics Making Rapid Progress with Both Personalized Medicine and Unique Medical Waste Disposal System
finance.yahoo.com - August 7 at 3:26 PM
German Stock Exchange approves delisting request of Precision TherapeuticsGerman Stock Exchange approves delisting request of Precision Therapeutics
seekingalpha.com - August 2 at 11:17 AM
Precision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment StrategiesPrecision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategies
finance.yahoo.com - July 17 at 3:24 PM
Precision Therapeutics nabs European patent covering Streamway; shares up 10%Precision Therapeutics nabs European patent covering Streamway; shares up 10%
seekingalpha.com - July 14 at 5:45 PM
Precision Therapeutics Inc. (AIPT) Secures European Patent for STREAMWAY System Covering Automated, Direct-to-Drain Medical Fluid DisposalPrecision Therapeutics Inc. (AIPT) Secures European Patent for STREAMWAY System Covering Automated, Direct-to-Drain Medical Fluid Disposal
www.streetinsider.com - July 14 at 5:45 PM
Precision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal SystemPrecision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal System
feeds.benzinga.com - July 12 at 8:09 PM
Precision Therapeutics Signs Definitive Merger Agreement with Helomics Holding CorporationPrecision Therapeutics Signs Definitive Merger Agreement with Helomics Holding Corporation
feeds.benzinga.com - June 28 at 8:16 PM
Precision Therapeutics Launches New WebsitePrecision Therapeutics Launches New Website
finance.yahoo.com - May 31 at 9:09 AM
Precision Therapeutics (AIPT) CEO Carl Schwartz on Q1 2018 Results - Earnings Call TranscriptPrecision Therapeutics' (AIPT) CEO Carl Schwartz on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 16 at 8:40 AM
Precision Therapeutics Reports First Quarter 2018 Financial ResultsPrecision Therapeutics Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 16 at 8:40 AM
This page was last updated on 3/21/2019 by MarketBeat.com Staff

Featured Article: What is the Coverage Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel